A Multiple Ascending Dose Study of R1507 in Patients With Advanced Solid Tumors.
NCT00400361
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
98
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasms
Interventions
DRUG:
RG1507
Sponsor
Hoffmann-La Roche